Nonalcoholic fatty liver disease (NAFLD) is a growing worldwide epidemic and an important
risk factor for the development of insulin resistance, type 2 diabetes, nonalcoholic …

Background & Aims The burden of nonalcoholic fatty liver disease (NAFLD) is increasing
worldwide. We performed a meta-analysis to determine the effectiveness of exercise-based …

Cancer is the second leading cause of death in the USA and among the leading major
diseases in the world. It is anticipated to continue to increase because of the growth of the …

Understanding the hepatic regenerative process has clinical interest as the effectiveness of
many treatments for chronic liver diseases is conditioned by efficient liver regeneration …

Background NAFLD is likely to become the most common cause of chronic liver disease.
The first-line treatment includes weight loss. Aims To analyze the impact of a hypocaloric …

Key points Physiologically relevant rodent models of non‐alcoholic steatohepatitis (NASH)
that resemble the human condition are limited. Exercise training and energy restriction are …

Nonalcoholic fatty liver disease (NAFLD) is on the rise and has become a major etiology for
chronic liver disease. It is frequently associated with obesity, insulin resistance …

National Institutes of Health Consensus Symposium in December 1998.(1) Since then, there
has been a rapid growth of knowledge regarding nonalcoholic fatty liver disease (NAFLD) in …

Aiming at investigating the potential effect of minimal dietary changes in NAFLD patients
with non-significant fibrosis, 55 patients with NAFLD were enrolled in a randomized …

Objectives: There is an urgent need to develop interventions and policies to mitigate the
health effects of obesity by targeting its metabolic mediators. Adrenomedullin 2 …